Patient information: uses, side effects, how to take - Takhzyro
What is TAKHZYRO?
TAKHZYRO is a prescription medicine used to prevent attacks of Hereditary Angioedema (HAE) in people 2 years of age and older.
It is not known if TAKHZYRO is safe and effective in children under 2 years of age.
Before you use TAKHZYRO, tell your healthcare provider about all of your medical conditions, including if you:
- are pregnant or planning to become pregnant. It is not known if TAKHZYRO can harm your unborn baby.
are breastfeeding or plan to breastfeed. It is not known if TAKHZYRO passes into your breastmilk. Talk to your healthcare provider about the best way to feed your baby while using TAKHZYRO.
Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, or herbal supplements.
How should I use TAKHZYRO?
- See the detailed Instructions for Use that comes with this patient information leaflet about the right way to prepare and inject TAKHZYRO.
- Use TAKHZYRO exactly as your healthcare provider tells you to use it.
- TAKHZYRO is given as an injection under your skin (subcutaneous) by you or a caregiver.
- Your healthcare provider should show you or your caregiver how to prepare and inject your dose of TAKHZYRO before you inject yourself for the first time.
- Do not try to inject TAKHZYRO unless you have been trained by your healthcare provider.
- Self-injection is not recommended in children (2 years to less than 12 years).
What are the possible side effects of TAKHZYRO?
TAKHZYRO may cause serious side effects, including allergic reactions. Allergic reactions may happen with TAKHZYRO. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:
- wheezing
- difficulty breathing
- chest tightness
- fast heartbeat
- faintness
- rash
- hives
The most common side effects of TAKHZYRO are:
- injection site reactions (pain, redness, and bruising)
- upper respiratory infections
- headache
- rash
- dizziness
- diarrhea
- muscle aches
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
General information about the safe and effective use of TAKHZYRO.
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use TAKHZYRO for a condition for which it is not prescribed. Do not give TAKHZYRO to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about TAKHZYRO that is written for health professionals.
What are the ingredients in TAKHZYRO?
Active ingredient: lanadelumab
Inactive ingredients: citric acid monohydrate, L-histidine, sodium chloride, sodium phosphate dibasic dihydrate and water for injection.
Manufactured by:
Takeda Pharmaceuticals U.S.A., Inc.
Cambridge, MA 02142
U.S. License No. 1898
TAKHZYRO is a registered trademark of Dyax Corp. Takeda and
are registered trademarks of Takeda Pharmaceutical Company Limited.
©2026 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved.
For more information, visit www.TAKHZYRO.com or call 1-877-TAKEDA-7 (1-877-825-3327).
INSTRUCTIONS FOR USE
TAKHZYRO® (tak-ZYE-roe)
(lanadelumab-flyo)
injection, for subcutaneous use
single-dose 1 mL prefilled syringe
This Instructions for Use contains information on how to inject TAKHZYRO. Please make sure to read, understand, and follow the Instructions for Use before injecting TAKHZYRO.
A healthcare provider should show you how to prepare and inject TAKHZYRO properly before you use it for the first time. Contact your healthcare provider if you have any questions.
| Important information: | |
| |
![]() Figure A: TAKHZYRO prefilled syringe | |
| Storing TAKHZYRO: | |
|
Step 1: Prepare for your injection
| |
![]() Figure B: Supplies | |
| ![]() |
| ![]() Figure C: Remove prefilled syringe |
| ![]() Figure D: Wash hands |
| ![]() Figure E: Location of expiration date |
| ![]() Figure F: Inspect the prefilled syringe |
| Step 2: Select and prepare injection site | |
Important: Change (rotate) injection sites to keep skin healthy. Each new injection should be given at least 1 inch from the last site you used. | ![]() Figure G: Injection sites |
| ![]() Figure H: Clean injection site |
| ![]() Figure I: Remove needle cap |
| |
Step 3: Inject TAKHZYRO
| ![]() Figure J: Grip prefilled syringe | |
| ![]() Figure K: Pinch a 1-inch fold of skin | |
| Figure L: Insert the needle | |
| ![]() Figure M: Push the plunger rod all the way down | |
| ||
| ||
Step 4: Throw away (dispose of) TAKHZYRO prefilled syringe
FDA-cleared sharps disposal containers are generally available through pharmacies, medical supply companies, healthcare providers, and online. | ![]() Figure O: Dispose in a sharps disposal container |
| |
Questions?
For product or service-related questions, call 1-877-TAKEDA-7 (1-877-825-3327) or go to www.TAKHZYRO.com.
Manufactured by:
Takeda Pharmaceuticals U.S.A., Inc.
Cambridge, MA 02142
U.S. License No. 1898
TAKHZYRO is a registered trademark of Dyax Corp. Takeda and
are registered trademarks of Takeda Pharmaceutical Company Limited.
©2026 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved.
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Approved: 8/2026
INSTRUCTIONS FOR USE
TAKHZYRO® (tak-ZYE-roe)
(lanadelumab-flyo)
injection, for subcutaneous use
single-dose 2mL prefilled syringe
This Instructions for Use contains information on how to inject TAKHZYRO. Please make sure to read, understand, and follow the Instructions for Use before injecting TAKHZYRO.
A healthcare provider should show you how to prepare and inject TAKHZYRO properly before you use it for the first time. Contact your healthcare provider if you have any questions.
| Important information: | |
| |
![]() Figure A: TAKHZYRO prefilled syringe | |
| Storing TAKHZYRO: | |
|
Step 1: Prepare for your injection
| |
![]() Figure B: Supplies | |
| ![]() |
| ![]() Figure C: Remove prefilled syringe |
| ![]() Figure D: Wash hands |
| ![]() Figure E: Location of expiration date |
| ![]() Figure F: Inspect the prefilled syringe |
| Step 2: Select and prepare injection site | |
| ![]() Figure G: Injection sites |
| ![]() Figure H: Clean injection site |
| ![]() Figure I: Remove needle cap |
| |
Step 3: Inject TAKHZYRO
| ![]() Figure J: Grip prefilled syringe | |
| ![]() Figure K: Pinch a 1-inch fold of skin | |
| Figure L: Insert the needle | |
| ![]() Figure M: Push the plunger rod all the way down | |
| ||
| ||
Step 4: Throw away (dispose of) TAKHZYRO prefilled syringe
FDA-cleared sharps disposal containers are generally available through pharmacies, medical supply companies, healthcare providers, and online. | ![]() Figure O: Dispose in a sharps disposal container |
| |
Questions?
For product or service-related questions, call 1-877-TAKEDA-7 (1-877-825-3327) or go to www.TAKHZYRO.com.
Manufactured by:
Takeda Pharmaceuticals U.S.A., Inc.
Cambridge, MA 02142
U.S. License No. 1898
TAKHZYRO is a registered trademark of Dyax Corp. Takeda and
are registered trademarks of Takeda Pharmaceutical Company Limited.
©2026 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved.
This Instructions for Use has been approved by the U.S Food and Drug Administration.
Approved: 8/2026













Figure L: Insert the needle














Figure L: Insert the needle

